Search Results - "Eric Grouzmann"

Refine Results
  1. 1

    Acute Effects of Lysergic Acid Diethylamide in Healthy Subjects by Schmid, Yasmin, Enzler, Florian, Gasser, Peter, Grouzmann, Eric, Preller, Katrin H, Vollenweider, Franz X, Brenneisen, Rudolf, Müller, Felix, Borgwardt, Stefan, Liechti, Matthias E

    Published in Biological psychiatry (1969) (15-10-2015)
    “…Abstract Background After no research in humans for >40 years, there is renewed interest in using lysergic acid diethylamide (LSD) in clinical psychiatric…”
    Get full text
    Journal Article
  2. 2

    Determination of catecholamines in plasma and urine by Grouzmann, Eric, Pharm.D., Ph.D, Lamine, Faiza, MD

    “…For more than 20 years, measurement of catecholamines in plasma and urine in clinical chemistry laboratories has been the cornerstone of the diagnosis of…”
    Get full text
    Journal Article
  3. 3

    Stabilization of urinary biogenic amines measured in clinical chemistry laboratories by Eugster, Philippe J., Centeno, Catherine, Dunand, Marielle, Seghezzi, Caroline, Grouzmann, Eric

    Published in Clinica chimica acta (01-03-2021)
    “…•We studied preanalytical stability of 9 currently measured biogenic amines in urine.•Stabilization by sodium citrate and HCl were compared with native…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6

    Impact of obesity with or without hypertension on systemic haemodynamic and renal responses to lower body negative pressure by Nima Vakilzadeh, Dusan Petrovic, Marc Maillard, Lucie Favre, Eric Grouzmann, Gregoire Wuerzner

    Published in Blood pressure (02-01-2021)
    “…Purpose Sodium and water handling by the kidney and the sympathetic nervous system have been implicated in the development of obesity-related hypertension and…”
    Get full text
    Journal Article
  7. 7

    Brain fog in neuropathic postural tachycardia syndrome may be associated with autonomic hyperarousal and improves after water drinking by Rodriguez, Belén, Hochstrasser, Annie, Eugster, Philippe J, Grouzmann, Eric, Müri, René M, Z'Graggen, Werner J

    Published in Frontiers in neuroscience (05-08-2022)
    “…Brain fog is a common and highly disturbing symptom for patients with neuropathic postural tachycardia syndrome (POTS). Cognitive deficits have been measured…”
    Get full text
    Journal Article
  8. 8

    Evaluation of a New 177Lu-Labeled Somatostatin Analog for the Treatment of Tumors Expressing Somatostatin Receptor Subtypes 2 and 5 by Mansi, Rosalba, Nicolas, Guillaume Pierre, Del Pozzo, Luigi, Abid, Karim Alexandre, Grouzmann, Eric, Fani, Melpomeni

    Published in Molecules (Basel, Switzerland) (11-09-2020)
    “…Targeted radionuclide therapy of somatostatin receptor (SST)-expressing tumors is only partially addressed by the established somatostatin analogs having an…”
    Get full text
    Journal Article
  9. 9

    Production and characterization of two major Aspergillus oryzae secreted prolyl endopeptidases able to efficiently digest proline-rich peptides of gliadin by Eugster, Philippe J, Salamin, Karine, Grouzmann, Eric, Monod, Michel

    “…Prolyl endopeptidases are key enzymes in the digestion of proline-rich proteins. Fungal extracts rich in prolyl endopeptidases produced by a species such as…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Bariatric Surgery Induces a Differential Effect on Plasma Aldosterone in Comparison to Dietary Advice Alone by Berney, Maxime, Vakilzadeh, Nima, Maillard, Marc, Faouzi, Mohamed, Grouzmann, Eric, Bonny, Olivier, Favre, Lucie, Wuerzner, Grégoire

    Published in Frontiers in endocrinology (Lausanne) (05-10-2021)
    “…The pathophysiological mechanisms linking weight loss to blood pressure (BP) reduction are not completely understood. The objective of this study was to…”
    Get full text
    Journal Article
  12. 12

    A Genetic Screen Identifies Hypothalamic Fgf15 as a Regulator of Glucagon Secretion by Picard, Alexandre, Soyer, Josselin, Berney, Xavier, Tarussio, David, Quenneville, Simon, Jan, Maxime, Grouzmann, Eric, Burdet, Frédéric, Ibberson, Mark, Thorens, Bernard

    Published in Cell reports (Cambridge) (08-11-2016)
    “…The counterregulatory response to hypoglycemia, which restores normal blood glucose levels to ensure sufficient provision of glucose to the brain, is critical…”
    Get full text
    Journal Article
  13. 13

    Low number of neurosecretory vesicles in neuroblastoma impairs massive catecholamine release and prevents hypertension by Mühlethaler-Mottet, Annick, Uccella, Silvia, Marchiori, Deborah, La Rosa, Stefano, Daraspe, Jean, Balmas Bourloud, Katia, Beck Popovic, Maja, Eugster, Philippe J, Grouzmann, Eric, Abid, Karim

    Published in Frontiers in endocrinology (Lausanne) (01-12-2022)
    “…Neuroblastoma (NB) is a pediatric cancer of the developing sympathetic nervous system. It produces and releases metanephrines, which are used as biomarkers for…”
    Get full text
    Journal Article
  14. 14

    Accurate Location of Catheter Tip With the Free-to-Total Metanephrine Ratio During Adrenal Vein Sampling by Christou, Foteini, Pivin, Edward, Denys, Alban, Abid, Karim A, Zingg, Tobias, Matter, Maurice, Pechère-Bertschi, Antoinette, Maillard, Marc, Grouzmann, Eric, Wuerzner, Gregoire

    Published in Frontiers in endocrinology (Lausanne) (24-02-2022)
    “…The selectivity index (SI) of cortisol is used to document correct catheter placement during adrenal vein sampling (AVS) in patients with primary aldosteronism…”
    Get full text
    Journal Article
  15. 15

    Diagnostic accuracy of free and total metanephrines in plasma and fractionated metanephrines in urine of patients with pheochromocytoma by Grouzmann, Eric, Drouard-Troalen, Laurence, Baudin, Eric, Plouin, Pierre-François, Muller, Beat, Grand, Daniela, Buclin, Thierry

    Published in European journal of endocrinology (01-05-2010)
    “…BackgroundPlasma free and urinary metanephrines are recognized biomarkers for the assessment of pheochromocytoma. Plasma total metanephrines with a long…”
    Get full text
    Journal Article
  16. 16

    Catecholamine metabolism in paraganglioma and pheochromocytoma: similar tumors in different sites? by Grouzmann, Eric, Tschopp, Oliver, Triponez, Frédéric, Matter, Maurice, Bilz, Stefan, Brändle, Michael, Drechser, Tilman, Sigrist, Sarah, Zulewski, Henryk, Henzen, Christoph, Fischli, Stefan, Abid, Karim

    Published in PloS one (06-05-2015)
    “…Pheochromocytoma (PHEO) and paraganglioma (PGL) are catecholamine-producing neuroendocrine tumors that arise respectively inside or outside the adrenal…”
    Get full text
    Journal Article
  17. 17

    Hypertension in a Patient With Polycystic Kidney Disease Complicated by Concomitant Pheochromocytoma by Ameti, Adelina, Kopp, Peter A., Pitteloud, Nelly, Wuerzner, Grégoire, Grouzmann, Eric, Matter, Maurice, Lamine, Faiza, Phan, Olivier

    Published in AACE clinical case reports (01-07-2024)
    “…Due to the high prevalence of hypertension in patients with autosomal dominant polycystic kidney disease (ADPKD) and advanced chronic kidney disease,…”
    Get full text
    Journal Article
  18. 18

    Neuropeptide Y and Derivates Are Not Ready for Prime Time in Prostate Cancer Early Detection by Maurer, Jonathan, Eugster, Philippe J., Collins, Kiana, Vocat, Céline, Oke, Jason, Nicholson, Brian, Rakauskas, Arnas, Grouzmann, Eric, Valerio, Massimo

    Published in European urology open science (Online) (01-08-2024)
    “…Neuropeptide Y (NPY) and related peptides have been proposed as promising biomarkers for the diagnosis of prostate cancer by previous immunoassays and…”
    Get full text
    Journal Article
  19. 19

    A new 68Ga-labeled somatostatin analog containing two iodo-amino acids for dual somatostatin receptor subtype 2 and 5 targeting by Mansi, Rosalba, Abid, Karim, Nicolas, Guillaume P., Del Pozzo, Luigi, Grouzmann, Eric, Fani, Melpomeni

    Published in EJNMMI research (05-08-2020)
    “…Background Somatostatin receptor (SST) targeting, specifically of the subtype 2 (SST2), with radiolabeled somatostatin analogs, is established for imaging and…”
    Get full text
    Journal Article
  20. 20

    Saxagliptin: A potential doping agent? A randomized, double‐blinded, placebo‐controlled, and crossover pilot study in young active men by Bourdillon, Nicolas, Eugster, Philippe J., Vocat, Céline, Nguyen, Toan, Wuerzner, Gregoire, Grouzmann, Eric, Millet, Grégoire P.

    Published in Physiological reports (01-12-2022)
    “…Neuropeptide Ys (NPYs) contribute to sympathetic‐adreno stimulation: NPY1‐36 potentiates the effects of catecholamines (CATs), whereas NPY3‐36 inhibits CAT…”
    Get full text
    Journal Article